Ads
related to: early testing for parkinson's side- Get Involved Today
Join our mission to end Parkinson's
You can make a difference
- Parkinson's Research News
The latest developments in research
Our research progress to date
- Understanding Parkinson's
Learn the basics of Parkinson's
Tips and Resources
- Our Mission
We're here for a Parkinson's cure
We put patients first
- Get Involved Today
Search results
Results from the WOW.Com Content Network
“The development of a biomarker test for early detection of Parkinson’s disease is a potentially transformative advancement,” said Dr. Daniel Truong, a neurologist and medical director of ...
An experimental blood test that detected Parkinson’s disease in a preliminary study could become the first specific tool for diagnosing the devastating neurodegenerative condition, researchers ...
A small new trial published in the journal Nature Medicine describes what would be two firsts for Parkinson's disease, if they pan out: a diagnostic test and a potential immune-based treatment ...
Parkinson's typically manifests in individuals over 60, with about one percent affected. In those younger than 50, it is termed "early-onset PD". No cure for Parkinson's is known, and treatment focuses on alleviating symptoms. Initial treatment typically includes L-DOPA, MAO-B inhibitors, or dopamine agonists.
Although this method can distinguish essential tremor from Parkinson's syndrome, it is unable to distinguish between Parkinson's disease, Dementia with Lewy bodies, Parkinson's disease dementia, [3] multiple system atrophy or progressive supranuclear palsy. There is evidence that DaTSCAN is accurate in diagnosing early Parkinson's. [4] [5]
Tavapadon, a drug being tested to treat early Parkinson's disease, has shown great promise in a Phase III trial by AbbVie, the pharmaceutical company announced this week. Parkinson’s disease ...
Ads
related to: early testing for parkinson's side